GO TO: Recent Comment Letters
ALL |
All 10-K/Qs
Large
Mid
Small
Micro
|
Earnings Release
Proxy
|
SORT BY :
Most Recent
Company Name
| Company | Time | Size | View | Financials | Document | SEC | Period | Revenue MRQ | Assets | EPS Diluted | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Tvardi Therapeutics, Inc. (TVRD) | 8/14/2026 7:23:15 AM | Micro | View | Financials | 10-Q | SEC | 2Q 2026 ending: 6/30/2026 | Assets $17,517,000 | EPS -$0.69 | ||
| Tvardi Therapeutics, Inc. (TVRD) | 8/14/2026 7:05:46 AM | View | Financials | Earnings | SEC | 2Q 2026 | Assets $17,517,000 | EPS -$0.69 | Export Earnings Model | ||
| Tvardi Therapeutics, Inc. (TVRD) | 5/8/2026 7:23:47 AM | Micro | View | Financials | 10-Q | SEC | 1Q 2026 ending: 3/31/2026 | Assets $25,817,000 | EPS -$0.73 | ||
| Tvardi Therapeutics, Inc. (TVRD) | 5/8/2026 7:06:28 AM | View | Financials | Earnings | SEC | 1Q 2026 | Assets $25,817,000 | EPS -$0.73 | Export Earnings Model | ||
| Tvardi Therapeutics, Inc. (TVRD) | 4/23/2026 4:30:58 PM | View | Proxy | SEC | Y 2025 | ||||||
| Tvardi Therapeutics, Inc. (TVRD) | 3/31/2026 4:23:06 PM | Micro | View | Financials | 10-K | SEC | Y 2025 ending: 12/31/2025 | Assets $32,073,000 | EPS -$3.26 | ||
| Tvardi Therapeutics, Inc. (TVRD) | 3/31/2026 4:17:38 PM | View | Financials | Earnings | SEC | Y 2025 | Assets $32,073,000 | EPS -$0.76 | Export Earnings Model | ||
| Tvardi Therapeutics, Inc. (TVRD) | 11/13/2025 4:24:25 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2025 ending: 9/30/2025 | Assets $39,021,000 | EPS -$0.59 | ||
| Tvardi Therapeutics, Inc. (TVRD) | 11/13/2025 4:16:55 PM | View | Financials | Earnings | SEC | 3Q 2025 | Assets $39,021,000 | EPS -$0.59 | Export Earnings Model | ||
| Tvardi Therapeutics, Inc. (TVRD) | 8/14/2025 4:39:09 PM | View | Financials | Earnings | SEC | 2Q 2025 | Assets $43,750,000 | EPS -$1.00 | Export Earnings Model | ||
| Tvardi Therapeutics, Inc. (TVRD) | 8/14/2025 4:26:28 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2025 ending: 6/30/2025 | Assets $43,750,000 | EPS -$1.00 | ||
| Tvardi Therapeutics, Inc. (TVRD) | 5/13/2025 4:28:13 PM | View | Financials | Earnings | SEC | 1Q 2025 | Rev $2,569,000 +20.3% | Assets $38,947,000 | EPS -$3.22 | Export Earnings Model | |
| Tvardi Therapeutics, Inc. (TVRD) | 5/13/2025 4:24:00 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2025 ending: 3/31/2025 | Rev: $2,569,000 +20.3% | Assets $38,947,000 | EPS -$3.22 | |
| Cara Therapeutics, Inc. (TVRD) | 3/11/2025 4:26:55 PM | Micro | View | Financials | 10-K | SEC | Y 2024 ending: 12/31/2024 | Rev: $7,137,000 -66.0% | Assets $43,827,000 | EPS -$15.53 | |
| Cara Therapeutics, Inc. (TVRD) | 11/14/2024 4:25:21 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2024 ending: 9/30/2024 | Rev: $2,556,000 -47.5% | Assets $51,329,000 | EPS -$2.73 | |
| Cara Therapeutics, Inc. (TVRD) | 8/14/2024 4:25:24 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2024 ending: 6/30/2024 | Rev: $991,000 -85.7% | Assets $72,495,000 | EPS -$0.37 | |
| Cara Therapeutics, Inc. (TVRD) | 5/13/2024 4:28:55 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2024 ending: 3/31/2024 | Rev: $2,135,000 -65.4% | Assets $90,099,000 | EPS -$20.24 | |
| Cara Therapeutics, Inc. (TVRD) | 5/13/2024 4:12:49 PM | View | Financials | Earnings | SEC | 1Q 2024 | Rev $2,135,000 -65.4% | Assets $90,099,000 | EPS -$20.24 | Export Earnings Model | |
| Cara Therapeutics, Inc. (TVRD) | 4/22/2024 4:07:49 PM | View | Proxy | SEC | Y 2023 | ||||||
| Cara Therapeutics, Inc. (TVRD) | 3/6/2024 4:25:55 PM | Micro | View | Financials | 10-K | SEC | Y 2023 ending: 12/31/2023 | Rev: $20,968,000 -49.9% | Assets $125,844,000 | EPS -$26.26 | |
| Cara Therapeutics, Inc. (TVRD) | 3/4/2024 4:12:19 PM | View | Financials | Earnings | SEC | Y 2023 | Rev $3,004,000 -7.9% | Assets $125,844,000 | EPS -$7.12 | Export Earnings Model | |
| Cara Therapeutics, Inc. (TVRD) | 11/13/2023 4:37:41 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2023 ending: 9/30/2023 | Rev: $4,866,000 -55.0% | Assets $115,338,000 | EPS -$6.20 | |
| Cara Therapeutics, Inc. (TVRD) | 11/13/2023 4:14:53 PM | View | Financials | Earnings | SEC | 3Q 2023 | Rev $4,866,000 -55.0% | Assets $115,338,000 | EPS -$6.20 | Export Earnings Model | |
| Cara Therapeutics, Inc. (TVRD) | 8/7/2023 4:29:32 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2023 ending: 6/30/2023 | Rev: $6,933,000 -69.9% | Assets $134,389,000 | EPS -$0.58 | |
| Cara Therapeutics, Inc. (TVRD) | 8/7/2023 4:11:28 PM | View | Financials | Earnings | SEC | 2Q 2023 | Rev $6,933,000 -69.9% | Assets $134,389,000 | EPS -$0.58 | Export Earnings Model | |
| Cara Therapeutics, Inc. (TVRD) | 5/15/2023 4:24:21 PM | Small | View | Financials | 10-Q | SEC | 1Q 2023 ending: 3/31/2023 | Rev: $6,165,000 +28.7% | Assets $153,276,000 | EPS -$0.49 | |
| Cara Therapeutics, Inc. (TVRD) | 5/15/2023 4:14:16 PM | View | Financials | Earnings | SEC | 1Q 2023 | Rev $6,165,000 +28.7% | Assets $153,276,000 | EPS -$0.49 | Export Earnings Model | |
| Cara Therapeutics, Inc. (TVRD) | 4/20/2023 4:21:06 PM | View | Proxy | SEC | Y 2022 | ||||||
| Cara Therapeutics, Inc. (TVRD) | 3/6/2023 4:27:55 PM | Small | View | Financials | 10-K | SEC | Y 2022 ending: 12/31/2022 | Rev: $41,867,000 +81.8% | Assets $182,237,000 | EPS -$19.12 | |
| Cara Therapeutics, Inc. (TVRD) | 3/6/2023 4:11:17 PM | View | Financials | Earnings | SEC | Y 2022 | Rev $3,261,000 +297.2% | Assets $182,237,000 | EPS -$18.09 | Export Earnings Model | |
| Cara Therapeutics, Inc. (TVRD) | 11/7/2022 4:29:52 PM | Small | View | Financials | 10-Q | SEC | 3Q 2022 ending: 9/30/2022 | Rev: $10,813,000 -46.7% | Assets $213,509,000 | EPS -$0.43 | |
| Cara Therapeutics, Inc. (TVRD) | 11/7/2022 4:13:34 PM | View | Financials | Earnings | SEC | 3Q 2022 | Rev $10,813,000 -46.7% | Assets $213,509,000 | EPS -$0.43 | Export Earnings Model | |
| Cara Therapeutics, Inc. (TVRD) | 8/8/2022 4:28:33 PM | Small | View | Financials | 10-Q | SEC | 2Q 2022 ending: 6/30/2022 | Rev: $23,003,000 | Assets $226,572,000 | EPS -$0.08 | |
| Cara Therapeutics, Inc. (TVRD) | 8/8/2022 4:13:09 PM | View | Financials | Earnings | SEC | 2Q 2022 | Rev $23,003,000 | Assets $226,572,000 | EPS -$0.08 | Export Earnings Model | |
| Cara Therapeutics, Inc. (TVRD) | 5/9/2022 4:27:56 PM | Small | View | Financials | 10-Q | SEC | 1Q 2022 ending: 3/31/2022 | Rev: $4,790,000 +147.5% | Assets $223,866,000 | EPS -$0.52 | |
| Cara Therapeutics, Inc. (TVRD) | 5/9/2022 4:14:56 PM | View | Financials | Earnings | SEC | 1Q 2022 | Rev $4,790,000 +147.5% | Assets $223,866,000 | EPS -$0.52 | Export Earnings Model | |
| Cara Therapeutics, Inc. (TVRD) | 4/22/2022 4:04:40 PM | View | Proxy | SEC | Y 2021 | ||||||
| Cara Therapeutics, Inc. (TVRD) | 3/1/2022 4:34:16 PM | Small | View | Financials | 10-K | SEC | Y 2021 ending: 12/31/2021 | Rev: $23,028,000 -83.0% | Assets $247,056,000 | EPS -$20.93 | |
| Cara Therapeutics, Inc. (TVRD) | 3/1/2022 4:25:37 PM | View | Financials | Earnings | SEC | Y 2021 | Rev $821,000 -99.3% | Assets $247,056,000 | EPS -$19.83 | Export Earnings Model | |
| Cara Therapeutics, Inc. (TVRD) | 1/10/2022 7:02:17 AM | View | Presentation | SEC | 1Q 2022 | ||||||
| Cara Therapeutics, Inc. (TVRD) | 11/8/2021 4:21:35 PM | Small | View | Financials | 10-Q | SEC | 3Q 2021 ending: 9/30/2021 | Rev: $20,272,000 +118.8% | Assets $225,092,000 | EPS -$0.02 | |
| Cara Therapeutics, Inc. (TVRD) | 11/8/2021 4:14:03 PM | View | Financials | Earnings | SEC | 3Q 2021 | Rev $20,272,000 +118.8% | Assets $225,092,000 | EPS -$0.02 | Export Earnings Model | |
| Cara Therapeutics, Inc. (TVRD) | 8/9/2021 4:23:33 PM | Small | View | Financials | 10-Q | SEC | 2Q 2021 ending: 6/30/2021 | Assets $221,454,000 | EPS -$0.61 | ||
| Cara Therapeutics, Inc. (TVRD) | 8/9/2021 4:16:16 PM | View | Financials | Earnings | SEC | 2Q 2021 | Assets $221,454,000 | EPS -$0.61 | Export Earnings Model | ||
| Cara Therapeutics, Inc. (TVRD) | 5/10/2021 4:23:36 PM | Small | View | Financials | 10-Q | SEC | 1Q 2021 ending: 3/31/2021 | Rev: $1,935,000 -76.1% | Assets $250,228,000 | EPS -$0.47 | |
| Cara Therapeutics, Inc. (TVRD) | 5/10/2021 4:13:17 PM | View | Financials | Earnings | SEC | 1Q 2021 | Rev $1,935,000 -76.1% | Assets $250,228,000 | EPS -$0.47 | Export Earnings Model | |
| Cara Therapeutics, Inc. (TVRD) | 4/23/2021 4:32:35 PM | View | Proxy | SEC | Y 2020 | ||||||
| Cara Therapeutics, Inc. (TVRD) | 2/25/2021 4:42:20 PM | Small | View | Financials | 10-K | SEC | Y 2020 ending: 12/31/2020 | Rev: $135,082,000 +579.3% | Assets $271,157,000 | EPS $0.18 | |
| Cara Therapeutics, Inc. (TVRD) | 2/25/2021 4:12:13 PM | View | Financials | Earnings | SEC | Y 2020 | Rev $112,089,000 +2,384.8% | Assets $271,157,000 | EPS $1.59 | Export Earnings Model | |
| Cara Therapeutics, Inc. (TVRD) | 11/9/2020 4:32:25 PM | Small | View | Financials | 10-Q | SEC | 3Q 2020 ending: 9/30/2020 | Rev: $9,266,000 +60.2% | Assets $147,136,000 | EPS -$0.35 | |
| Cara Therapeutics, Inc. (TVRD) | 11/9/2020 4:11:55 PM | View | Financials | Earnings | SEC | 3Q 2020 | Rev $9,266,000 +60.2% | Assets $147,136,000 | EPS -$0.35 | Export Earnings Model | |
| Cara Therapeutics, Inc. (TVRD) | 8/10/2020 4:36:32 PM | Small | View | Financials | 10-Q | SEC | 2Q 2020 ending: 6/30/2020 | Rev: $5,634,000 +8.2% | Assets $168,613,000 | EPS -$0.54 | |
| Cara Therapeutics, Inc. (TVRD) | 8/10/2020 4:14:31 PM | View | Financials | Earnings | SEC | 2Q 2020 | Rev $5,634,000 +8.2% | Assets $168,613,000 | EPS -$0.54 | Export Earnings Model | |
| Cara Therapeutics, Inc. (TVRD) | 5/11/2020 4:42:56 PM | Small | View | Financials | 10-Q | SEC | 1Q 2020 ending: 3/31/2020 | Rev: $8,093,000 +84.7% | Assets $196,173,000 | EPS -$0.62 | |
| Cara Therapeutics, Inc. (TVRD) | 5/11/2020 4:22:53 PM | View | Financials | Earnings | SEC | 1Q 2020 | Rev $8,093,000 +84.7% | Assets $196,173,000 | EPS -$0.62 | Export Earnings Model | |
| Cara Therapeutics, Inc. (TVRD) | 4/22/2020 4:31:38 PM | View | Proxy | SEC | Y 2019 | ||||||
| Cara Therapeutics, Inc. (TVRD) | 2/27/2020 5:43:13 PM | Small | View | Financials | 10-K | SEC | Y 2019 ending: 12/31/2019 | Rev: $19,886,000 +47.6% | Assets $232,959,000 | EPS -$2.49 | |
| Cara Therapeutics, Inc. (TVRD) | 2/27/2020 4:28:14 PM | View | Financials | Earnings | SEC | Y 2019 | Rev $4,511,000 -18.5% | Assets $232,959,000 | EPS -$0.61 | Export Earnings Model | |
| Cara Therapeutics, Inc. (TVRD) | 11/5/2019 5:28:00 PM | Small | View | Financials | 10-Q | SEC | 3Q 2019 ending: 9/30/2019 | Rev: $5,785,000 +14.3% | Assets $263,795,000 | EPS -$0.74 | |
| Cara Therapeutics, Inc. (TVRD) | 11/5/2019 4:09:47 PM | View | Financials | Earnings | SEC | 3Q 2019 | Rev $5,785,000 +14.3% | Assets $263,795,000 | EPS -$0.74 | Export Earnings Model | |
| Cara Therapeutics, Inc. (TVRD) | 8/7/2019 5:17:08 PM | Small | View | Financials | 10-Q | SEC | 2Q 2019 ending: 6/30/2019 | Rev: $5,208,000 +81.2% | Assets $149,641,000 | EPS -$0.58 | |
| Cara Therapeutics, Inc. (TVRD) | 8/7/2019 4:16:45 PM | View | Financials | Earnings | SEC | 2Q 2019 | Rev $5,208,000 +81.2% | Assets $149,641,000 | EPS -$0.58 | Export Earnings Model | |
| Cara Therapeutics, Inc. (TVRD) | 5/7/2019 5:32:01 PM | Small | View | Financials | 10-Q | SEC | 1Q 2019 ending: 3/31/2019 | Rev: $4,382,000 | Assets $170,587,000 | EPS -$0.56 | |
| Cara Therapeutics, Inc. (TVRD) | 5/7/2019 4:18:04 PM | View | Financials | Earnings | SEC | 1Q 2019 | Rev $4,382,000 | Assets $170,587,000 | EPS -$0.56 | Export Earnings Model | |
| Cara Therapeutics, Inc. (TVRD) | 4/24/2019 4:18:05 PM | View | Proxy | SEC | Y 2018 | ||||||
| Cara Therapeutics, Inc. (TVRD) | 3/12/2019 5:14:01 PM | Small | View | Financials | 10-K | SEC | Y 2018 ending: 12/31/2018 | Rev: $13,469,000 +1,378.5% | Assets $190,823,000 | EPS -$2.06 | |
| Cara Therapeutics, Inc. (TVRD) | 3/12/2019 4:12:02 PM | View | Financials | Earnings | SEC | Y 2018 | Rev $5,533,000 | Assets $190,823,000 | EPS -$0.52 | Export Earnings Model | |
| Cara Therapeutics, Inc. (TVRD) | 11/6/2018 5:03:35 PM | Small | View | Financials | 10-Q | SEC | 3Q 2018 ending: 9/30/2018 | Rev: $5,062,000 | Assets $212,704,000 | EPS -$0.51 | |
| Cara Therapeutics, Inc. (TVRD) | 11/6/2018 4:17:32 PM | View | Financials | Earnings | SEC | 3Q 2018 | Rev $5,062,000 | Assets $212,704,000 | EPS -$0.51 | Export Earnings Model | |
| Cara Therapeutics, Inc. (TVRD) | 8/7/2018 5:16:36 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2018 ending: 6/30/2018 | Rev: $2,874,000 | Assets $139,893,000 | EPS -$0.52 | |
| Cara Therapeutics, Inc. (TVRD) | 8/7/2018 4:22:10 PM | View | Financials | Earnings | SEC | 2Q 2018 | Rev $2,874,000 | Assets $139,893,000 | EPS -$0.52 | Export Earnings Model | |
| Cara Therapeutics, Inc. (TVRD) | 7/17/2018 5:26:44 PM | View | Presentation | SEC | 3Q 2018 | ||||||
| Cara Therapeutics, Inc. (TVRD) | 5/9/2018 5:30:26 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2018 ending: 3/31/2018 | Assets $80,635,000 | EPS -$0.51 | ||
| Cara Therapeutics, Inc. (TVRD) | 5/9/2018 4:16:05 PM | View | Financials | Earnings | SEC | 1Q 2018 | Assets $80,635,000 | EPS -$0.51 | Export Earnings Model | ||
| Cara Therapeutics, Inc. (TVRD) | 4/26/2018 4:21:45 PM | View | Proxy | SEC | Y 2017 | ||||||
| Cara Therapeutics, Inc. (TVRD) | 3/15/2018 5:30:00 PM | Micro | View | Financials | 10-K | SEC | Y 2017 ending: 12/31/2017 | Rev: $911,000 +959.3% | Assets $97,004,000 | EPS -$1.86 | |
| Cara Therapeutics, Inc. (TVRD) | 3/15/2018 4:13:47 PM | View | Financials | Earnings | SEC | Y 2017 | Rev $0 | Assets $97,004,000 | EPS -$0.43 | Export Earnings Model | |
| Cara Therapeutics, Inc. (TVRD) | 11/2/2017 5:23:18 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2017 ending: 9/30/2017 | Assets $108,047,000 | EPS -$0.38 | ||
| Cara Therapeutics, Inc. (TVRD) | 11/2/2017 4:10:55 PM | View | Financials | Earnings | SEC | 3Q 2017 | Assets $108,047,000 | EPS -$0.38 | Export Earnings Model | ||
| Cara Therapeutics, Inc. (TVRD) | 8/3/2017 5:22:19 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2017 ending: 6/30/2017 | Assets $117,973,000 | EPS -$0.29 | ||
| Cara Therapeutics, Inc. (TVRD) | 8/3/2017 4:11:06 PM | View | Financials | Earnings | SEC | 2Q 2017 | Assets $117,973,000 | EPS -$0.29 | Export Earnings Model | ||
| Cara Therapeutics, Inc. (TVRD) | 5/10/2017 4:06:06 PM | View | Proxy | SEC | Y 2016 | ||||||
| Cara Therapeutics, Inc. (TVRD) | 5/4/2017 5:35:39 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2017 ending: 3/31/2017 | Rev: $911,000 +12,914.3% | Assets $43,299,000 | EPS -$0.81 | |
| Cara Therapeutics, Inc. (TVRD) | 5/4/2017 4:11:56 PM | View | Financials | Earnings | SEC | 1Q 2017 | Rev $911,000 +12,914.3% | Assets $43,299,000 | EPS -$0.81 | Export Earnings Model | |
| Cara Therapeutics, Inc. (TVRD) | 3/10/2017 5:30:00 AM | Micro | View | Financials | 10-K | SEC | Y 2016 ending: 12/31/2016 | Rev: $86,000 -97.7% | Assets $63,828,000 | EPS -$2.10 | |
| Cara Therapeutics, Inc. (TVRD) | 3/9/2017 4:10:55 PM | View | Financials | Earnings | SEC | Y 2016 | Rev $0 | Assets $63,828,000 | EPS -$0.81 | Export Earnings Model | |
| Cara Therapeutics, Inc. (TVRD) | 11/4/2016 5:30:00 AM | Micro | View | Financials | 10-Q | SEC | 3Q 2016 ending: 9/30/2016 | Assets $80,152,000 | EPS -$0.42 | ||
| Cara Therapeutics, Inc. (TVRD) | 11/3/2016 4:11:02 PM | View | Financials | Earnings | SEC | 3Q 2016 | Assets $80,152,000 | EPS -$0.42 | Export Earnings Model | ||
| Cara Therapeutics, Inc. (TVRD) | 8/4/2016 5:26:59 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2016 ending: 6/30/2016 | Rev: $79,000 -91.0% | Assets $92,045,000 | EPS -$0.48 | |
| Cara Therapeutics, Inc. (TVRD) | 8/4/2016 4:15:57 PM | View | Financials | Earnings | SEC | 2Q 2016 | Rev $79,000 -91.0% | Assets $92,045,000 | EPS -$0.48 | Export Earnings Model | |
| Cara Therapeutics, Inc. (TVRD) | 5/5/2016 5:26:26 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2016 ending: 3/31/2016 | Rev: $7,000 -98.6% | Assets $102,013,000 | EPS -$0.39 | |
| Cara Therapeutics, Inc. (TVRD) | 5/5/2016 4:19:29 PM | View | Financials | Earnings | SEC | 1Q 2016 | Rev $7,000 -98.6% | Assets $102,013,000 | EPS -$0.39 | Export Earnings Model | |
| Cara Therapeutics, Inc. (TVRD) | 4/27/2016 4:05:38 PM | View | Proxy | SEC | Y 2015 | ||||||
| Cara Therapeutics, Inc. (TVRD) | 3/11/2016 5:30:00 AM | Micro | View | Financials | 10-K | SEC | Y 2015 ending: 12/31/2015 | Rev: $3,803,000 +19.7% | Assets $110,897,000 | EPS -$1.00 | |
| Cara Therapeutics, Inc. (TVRD) | 3/10/2016 4:15:59 PM | View | Financials | Earnings | SEC | Y 2015 | Rev $0 | Assets $110,897,000 | EPS -$0.35 | Export Earnings Model | |
| Cara Therapeutics, Inc. (TVRD) | 11/9/2015 5:15:32 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2015 ending: 9/30/2015 | Rev: $2,440,000 +116.9% | Assets $117,897,000 | EPS -$0.19 | |
| Cara Therapeutics, Inc. (TVRD) | 11/9/2015 4:11:00 PM | View | Financials | Earnings | SEC | 3Q 2015 | Rev $2,440,000 +116.9% | Assets $117,897,000 | EPS -$0.19 | Export Earnings Model | |
| Cara Therapeutics, Inc. (TVRD) | 8/10/2015 4:31:18 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2015 ending: 6/30/2015 | Rev: $874,000 -9.0% | Assets $46,441,000 | EPS -$0.25 | |
| Cara Therapeutics, Inc. (TVRD) | 8/10/2015 4:20:01 PM | View | Financials | Earnings | SEC | 2Q 2015 | Rev $874,000 -9.0% | Assets $46,441,000 | EPS -$0.25 | Export Earnings Model | |
| Cara Therapeutics, Inc. (TVRD) | 7/31/2015 6:08:53 AM | View | Financials | Earnings | SEC | 2Q 2015 | Rev $874,000 -9.0% | Assets $46,441,000 | EPS -$0.25 | Export Earnings Model | |
| Cara Therapeutics, Inc. (TVRD) | 5/12/2015 5:23:53 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2015 ending: 3/31/2015 | Rev: $489,000 +174.7% | Assets $51,654,000 | EPS -$0.21 | |
| Cara Therapeutics, Inc. (TVRD) | 5/12/2015 4:14:04 PM | View | Financials | Earnings | SEC | 1Q 2015 | Rev $489,000 +174.7% | Assets $51,654,000 | EPS -$0.21 | Export Earnings Model | |
| Cara Therapeutics, Inc. (TVRD) | 4/24/2015 4:18:37 PM | View | Proxy | SEC | Y 2014 | ||||||
| Cara Therapeutics, Inc. (TVRD) | 3/27/2015 5:30:00 AM | Micro | View | Financials | 10-K | SEC | Y 2014 ending: 12/31/2014 | Rev: $3,177,000 -73.4% | Assets $55,934,000 | EPS -$0.85 | |
| Cara Therapeutics, Inc. (TVRD) | 3/26/2015 4:11:33 PM | View | Financials | Earnings | SEC | Y 2014 | Rev $914,000 -6.1% | Assets $55,934,000 | EPS -$0.18 | Export Earnings Model | |
| Cara Therapeutics, Inc. (TVRD) | 11/10/2014 5:21:12 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2014 ending: 9/30/2014 | Rev: $1,125,000 +10.5% | Assets $62,372,000 | EPS -$0.29 | |
| Cara Therapeutics, Inc. (TVRD) | 11/10/2014 4:12:35 PM | View | Financials | Earnings | SEC | 3Q 2014 | Rev $1,125,000 +10.5% | Assets $62,372,000 | EPS -$0.29 | Export Earnings Model | |
| Cara Therapeutics, Inc. (TVRD) | 8/7/2014 5:26:11 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2014 ending: 6/30/2014 | Rev: $960,000 -90.4% | Assets $68,194,000 | EPS -$0.16 | |
| Cara Therapeutics, Inc. (TVRD) | 8/7/2014 4:19:36 PM | View | Financials | Earnings | SEC | 2Q 2014 | Rev $960,000 -90.4% | Assets $68,194,000 | EPS -$0.16 | Export Earnings Model | |
| Cara Therapeutics, Inc. (TVRD) | 5/12/2014 5:24:43 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2014 ending: 3/31/2014 | Rev: $178,000 | Assets $71,555,000 | EPS -$0.22 | |
| Cara Therapeutics, Inc. (TVRD) | 5/12/2014 4:11:06 PM | View | Financials | Earnings | SEC | 1Q 2014 | Rev $178,000 | Assets $71,555,000 | EPS -$0.22 | Export Earnings Model | |
| Cara Therapeutics, Inc. (TVRD) | 3/27/2014 4:16:52 PM | View | Financials | Earnings | SEC | Y 2013 | Rev $973,000 | Assets $18,083,000 | EPS -$0.49 | Export Earnings Model |